Skip to main content
SpringerLink
Log in

Relationship Between Xanthine Oxidase, Ischemia Modified Albumin, Nitric Oxide with Antioxidants in Non Pregnants, Pre and Post-delivery of Normal Pregnants and Preeclampsia

  • Original Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Preeclampsia is a multisystem disorder involves altered homeostasis of oxidants–antioxidants, inflammatory process and endothelial dysfunction. The present study aim was to determine the levels of oxidative stress parameters (malondialdehyde, protein carbonyl, ischemia modified albumin and xanthine oxidase), nutrient antioxidants (vitamin C and vitamin E), enzyme antioxidants (catalase, superoxide dismutase, glutathione peroxidase glutathione reductase), total antioxidant status (TAS) and its association with nitric oxide. The study population consists of three groups, non pregnants (Group 1, n = 57), normotensive pregnants (Group 2, n = 57) and Preeclampsia (Group 3, n = 57). Group 2 and 3 were followed after delivery within 48 h. In preeclampsia xanthine oxidase, malondialdehyde and uric acid levels were significantly increased (p < 0.001), while TAS decreased (p < 0.05) when compared to normotensive pregnant and non pregnant. Catalase, glutathione reductase levels were increased (p < 0.005) and vitamin E, super oxide dismutase levels were decreased (p < 0.001) in preeclampsia when compared to normal pregnants. Receiver operating characteristics curve analysis showed area under curve for xanthine oxidase (0.8), malondialdehyde (0.804), Uric acid (0.84), ischemia modified albumin (0.92) and catalase (0.88) which indicated as good markers in preeclampsia. Amongst, ischemia modified albumin is a better marker of intrauterine hypoxic reperfusion risk with sensitivity 87.7 % and specificity 91.2 %. The increased hydrogen peroxide from xanthine oxidase adds to oxidative stress and increased catalase activity in preeclampsia represents combating action. Increased oxidative stress, decreased TAS and its apparent reversible changes evinced within 48 h after delivery in preeclampsia illustrated that placental abnormality is the contributing factor in the pathogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Sibai BM. Hypertensive disorders of pregnancy: the United States prospective. Curr Opin Obstet Gynecol. 2008;20:102–6.

    Article  PubMed  Google Scholar 

  2. Betran AP, Wojdyla D, Posner SF, Gülmezoglu AM. National estimates for maternal mortality: an analysis based on the WHO systematic review of maternal mortality and morbidity. BMC Public Health. 2005;5:131.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Kurlak LO, Green A, Loughna P, Broughton Pipkin F. Oxidative stress markers in hypertensive states of pregnancy: preterm and term disease. Front Physiol. 2014. doi:10.3389/fphys.2014.00310.

    PubMed  PubMed Central  Google Scholar 

  4. Bilodeau JF. Review: maternal and placental antioxidant response to preeclampsia—impact on vasoactive eicosanoids. Placenta. 2014;35:S32–8.

    Article  CAS  PubMed  Google Scholar 

  5. Karacay O, SepiciDincel A, Karcaaltincaba D, Sahin D, Yalvaç S, Akyol M, et al. A quantitative evaluation of total antioxidant status andoxidative stress markers in preeclampsia and gestational diabetic patients in 24–36 weeks of gestation. Diabetes Res Clin Pract. 2010;89(3):231–8.

    Article  CAS  PubMed  Google Scholar 

  6. Bambrana V, Dayanand CD, Kotur PP. Is xanthine oxidase, a marker in pre-eclampsia? A case–control study. J Clin Diagn Res. 2015;9(10):BC 1–3.

    Google Scholar 

  7. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 1978;52:302–10.

    Article  CAS  PubMed  Google Scholar 

  8. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990;186:464–78.

    Article  CAS  PubMed  Google Scholar 

  9. Bergmeyer HU, Gawehn K, Grassl M. Glutathione reductase. In: Bergmeyer HU, editor. Methods of enzymatic analysis. New York: Academic Press; 1974. p. 465–6.

    Google Scholar 

  10. Bar Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia—a preliminary report. J Emerg Med. 2000;19(4):311–5.

    Article  CAS  Google Scholar 

  11. Trivedi RC, Rebar L, Berta E, Stong L. New enzymatic method for serum uric acid at 500 nm. Clin Chem. 1978;24(11):1908–11.

    CAS  PubMed  Google Scholar 

  12. Cortas NK, Wakid NW. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem. 1990;36:1440–3.

    CAS  PubMed  Google Scholar 

  13. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem. 1996;239(1):70–6.

    Article  CAS  PubMed  Google Scholar 

  14. Kakkar P, Das B, Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys. 1984;21(2):130–2.

    CAS  PubMed  Google Scholar 

  15. Mavis RD, Stellwagen E. Purification and subunit structure of glutathione reductase from bakers’ yeast. J Biol Chem. 1968;243(4):809–14.

    CAS  PubMed  Google Scholar 

  16. Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121–6.

    Article  CAS  PubMed  Google Scholar 

  17. Roe JH. Comparative analyses for ascorbic acid by the 2, 4-dinitrophenylhydrazine method with the coupling reaction at different temperatures: a procedure for determining specificity. J Biol Chem. 1961;236:1611–3.

    CAS  PubMed  Google Scholar 

  18. Martinek RG. Method for the determination of vitamin E (total tocopherols) in serum. Clin Chem. 1964;10:1078–86.

    CAS  PubMed  Google Scholar 

  19. Many A, Hubel CA, Roberts JM. Hyperuricemia and xanthine oxidase in preeclampsia, revisited. Am J Obstet Gynecol. 1996;174:288–91.

    Article  CAS  PubMed  Google Scholar 

  20. Murata M, Fukushima K, Takao T, Seki H, Takeda S, Wake N. Oxidative stress produced by xanthine oxidase induces apoptosis in human extravillous trophoblast cells. J Reprod Dev. 2013;59(1):7–13.

    Article  CAS  PubMed  Google Scholar 

  21. Kaur G, Mishra S, Sehgal A, Prasad R. Alterations in lipid peroxidation and antioxidant status in pregnancy with preeclampsia. Mol Cell Biochem. 2008;313:37–44.

    Article  CAS  PubMed  Google Scholar 

  22. Zusterzeel PL, Mulder TP, Peters WH, Wiseman SA, Steegers EA. Plasma protein carbonyls in nonpregnant, healthy pregnant and preeclamptic women. Free Radic Res. 2000;33(5):471–6.

    Article  CAS  PubMed  Google Scholar 

  23. Bakacak M, Kılınç M, Serin S, Ercan Ö, Köstü B, Avcı F, et al. Changes in copper, zinc, and malondialdehyde levels and superoxide dismutase activities in pre-eclamptic pregnancies. Med Sci Monit. 2015;21:2414–20.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Khera A, Vanderlelie JJ, Perkins AV. Selenium supplementation protects trophoblast cells from mitochondrial oxidative stress. Placenta. 2013;34(7):594–8.

    Article  CAS  PubMed  Google Scholar 

  25. Suhail M, FaizulSuhail M, Khan H. Role of vitamins C and e in regulating antioxidant and pro-oxidant markers in preeclampsia. J Clin Biochem Nutr. 2008;43(3):210–20.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Ikpen MA, Eigbefoh J, Eifediyi RA, Isabu PA, Okogbenin S, Okogbo FO, et al. Determination of antioxidant status of pre-eclamptic and normotensive sub-rural Nigerian pregnant women at the Irrua Specialist Teaching Hospital, Irrua, Edo State. J Matern Fetal Neonatal Med. 2012;25(10):2046–50.

    Article  CAS  PubMed  Google Scholar 

  27. Papageorghiou AT, Prefumo F, Leslie K, Gaze DC, Collinson PO. ThilaganathanB. Defective endovascular trophoblast invasion in the first trimester is associated with increased maternal serum ischemia-modified albumin. Hum Reprod. 2008;23(4):803–6.

    Article  CAS  PubMed  Google Scholar 

  28. Soto ME, Soria-Castro E, Lans VG, Ontiveros EM, Mejia BI, Hernandez HJ, et al. Analysis of oxidative stress enzymes and structural and functional proteins on human aortic tissue from different aortopathies. Oxid Med Cell Longev. 2014;. doi:10.1155/2014/760694.

    PubMed  PubMed Central  Google Scholar 

  29. Kenet G, Freedman J, Shenkman B, Regina E, Brok-Simoni F, Holzman F, et al. Plasma glutathione peroxidase deficiency and platelet insensitivity to nitric oxide in children with familial stroke. Arterioscler Thromb Vasc Biol. 1999;19(8):2017–23.

    Article  CAS  PubMed  Google Scholar 

  30. Fabbrini E, Serafini M, Colic Baric I, Hazen SL, Klein S. Effect of plasma uric acid on antioxidant capacity, oxidative stress, and insulin sensitivity in obese subjects. Diabetes. 2014;63(3):976–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Vanderlelie J, Gude N, Perkins AV. Antioxidant gene expression in preeclamptic placentae: a preliminary investigation. Placenta. 2008;29(6):519–22.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to thank the authorities of Sri Devaraj Urs Academy of Higher Education and Research for supporting this doctoral study.

Funding

Self-funded.

Author information

Authors and Affiliations

  1. Department of Biochemistry, Sri Devaraj Urs Medical College, SDUAHER, Kolar, Karnataka, 563 101, India

    Vanishree Bambrana & C. D. Dayanand

  2. Department of Obstetrics and Gynecology, Sri Devaraj Urs Medical College, SDUAHER, Kolar, Karnataka, 563 101, India

    Pushpa Kotur

Authors
  1. Vanishree Bambrana
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. D. Dayanand
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pushpa Kotur
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. D. Dayanand.

Ethics declarations

Conflict of interest

Mrs. Vanishree Bambrana, Dr. C. D. Dayanand and Dr. Pushpa Kotur declare that they have no conflict of interest. Financial support for this work borne by authors.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Research Involving Human Participants and/or Animals

This is non interventional study. Sample collection from human participants under taken after obtaining Institutional Ethical Committee approval. An appropriate individual patient informed consent used for sample collection. This article does not contain any studies with animals performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bambrana, V., Dayanand, C.D. & Kotur, P. Relationship Between Xanthine Oxidase, Ischemia Modified Albumin, Nitric Oxide with Antioxidants in Non Pregnants, Pre and Post-delivery of Normal Pregnants and Preeclampsia. Ind J Clin Biochem 32, 171–178 (2017). https://doi.org/10.1007/s12291-016-0599-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-016-0599-0

Keywords

Search

Navigation